NBMI Treatment in Patients With Mercury Toxicity

Clinical trial NCT04183595 · UNKNOWN

Trial details

NCT number: NCT04183595
Sponsor: EmeraMed
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Mercury Poisoning

Start date: 2023-11-22
Primary completion: 2024-05-22
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.